(Q41529350)

2 October 2017

1 reference

title

Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996. (English)

1 reference

Hormone Replacement Therapy

2 October 2017

main subject

1 reference

Gelfand MM

1

1 reference

2 October 2017

Wiita B

series ordinal

2

1 reference

2 October 2017

language of work or name

1 reference

1 May 1997

1 reference

2 October 2017

published in

Clinical Therapeutics

1 reference

2 October 2017

volume

19

1 reference

2 October 2017

issue

3

1 reference

2 October 2017

page(s)

383-404; discussion 367-8

1 reference

Androgens in men--uses and abuses

2 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Clinical review 82: Androgens and the postmenopausal woman

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

The Hormonal Activity of the Postmenopausal Ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Metabolic clearance rates of androgens and oestrogens in ageing women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Stanozolol in postmenopausal osteoporosis: Therapeutic efficacy and possible mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Therapeutic effects of methyl androstenediol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

A comparative controlled study of hormones used in the prevention of postpartum breast engorgement and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Effective treatment of dysmenorrhea and menstrual molimina by the preovulatory administration of methyltestosterone or methylandrostenediol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Preovulatory administration of methyltestosterone in refractory functional dysmenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Male hormone in the treatment of the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Evaluation of an estrogen, androgen, estrogen-androgen combination, and a placebo in the treatment of the menopause

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Suppression of lactation. Use of a fluoxymesterone-ethinyl estradiol combination

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Conservative treatment and therapeutic test for endometriosis by androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Oxymetholone as an anabolic agent in geriatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Comparison of oral estrogens and estrogens plus androgen on bone mineral density, menopausal symptoms, and lipid-lipoprotein profiles in surgical menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Suppression of lactation with fluoxymesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Menopause and risk factors for coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Changes in serum lipids and urinary ketosteroids during oral and intramuscular administration of androsterone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

High-density lipoprotein cholesterol is not decreased if an aromatizable androgen is administered

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Lipid metabolism in young males with hypotestosteronaemia and oligospermia prior to, during, and after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Reduction in high density lipoproteins by anabolic steroid (stanozolol) therapy for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Circulating lipid and lipoprotein concentrations with oral estrogen-androgen hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Androgenic steroid effects on liver and red cells

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

The impact of long-term testosterone replacement therapy on lipid and lipoprotein profiles in women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Changes in lipids and lipoproteins with long-term estrogen deficiency and hormone replacement therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Two cases of acute myocardial infarction associated with aplastic anemia during treatment with anabolic steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Low-dosage androgen-estrogen therapy in the older age group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Aortic distensibility in post-menopausal women receiving Tibolone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Hepatic lesions in patients treated with synthetic anabolic steriods

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Hyperplasia and prolapse of hepatocytes into hepatic veins during longterm methyltestosteronetherapy: possible relationships of these changes to the development of peliosis hepatis and liver tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Oral methyltestosterone and jaundice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Jaundice during methyl testosterone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

METHYLTESTOSTERONE, RELATED STEROIDS, AND LIVER FUNCTION.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Androgen-induced hepatoma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Liver pathology associated with the use of anabolic-androgenic steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Anabolic Steroid Dependence with Opioid-Type Features

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Methyltestosterone‐induced liver‐cell tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Liver damage from long-term methyltestosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Peliosis hepatis in a child

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Jaundice associated with norethandrolone (nilevar) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Methyltestosterone-induced cholestasis. The importance of disproportionately low serum alkaline phosphatase level

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Peliosis hepatis and cholestasis following administration of norethandrolone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Jaundice due to methyltestosterone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Biliary Cirrhosis Following the Administration of Methyltestosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Androgenic-anabolic steroid therapy and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Androgens and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

Androgen associated hepatocellular carcinoma with an aggressive course.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2897%2980125-7

7 January 2021

10.1016/S0149-2918(97)80125-7

Identifiers

DOI

1 reference

release_f6q2cp6snncedmbbaq6qje63t4

2 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f6q2cp6snncedmbbaq6qje63t4

24 November 2022

mapped directly with Wikidata item

1 reference